Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

586
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
586
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

322
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
322
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

491
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
491
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

216
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
216

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainable vitreoretinal surgery: balancing environmental responsibility with patient choice.

Eye (London, England)·2026
Same author

Pembrolizumab-associated choroidal inflammation on a background of treated choroidal melanoma.

BMJ case reports·2026
Same author

GWAS meta-analysis provides new insights into uveal melanoma risk.

British journal of cancer·2026
Same author

Impact of preoperative education on early outcomes following hip and knee arthroplasty : a 21,000-patient multicentre NHS analysis.

Bone & joint open·2026
Same author

The complement system contributes to the immunosuppressive microenvironment of uveal melanoma.

Journal of translational medicine·2026
Same author

Validation of MOLES score for small choroidal melanomas: impact of assuming enlargement for telemedicine in sizable lesions.

Eye (London, England)·2026

Related Experiment Video

Updated: Dec 23, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.0K

Parsimonious Models for Predicting Mortality from Choroidal Melanoma.

Bertil Damato, Antonio Eleuteri1, Rumana Hussain

  • 1,.

Investigative Ophthalmology & Visual Science
|April 26, 2020
PubMed
Summary

New models using largest basal tumor diameter and chromosome 3 status can predict metastasis mortality in choroidal melanoma patients when standard tools are unavailable. These models offer accurate risk assessment for metastatic death.

More Related Videos

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.9K
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

2.1K

Related Experiment Videos

Last Updated: Dec 23, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.0K
A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

12.9K
Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
05:46

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Published on: December 2, 2022

2.1K

Area of Science:

  • Ophthalmology
  • Oncology
  • Biostatistics

Background:

  • Choroidal melanoma is a rare eye cancer with a significant risk of metastasis.
  • Accurate prognostication is crucial for patient management, but current tools like the Liverpool Uveal Melanoma Prognosticator Online (LUMPO) and Tumor, Node, Metastasis (TNM) staging system may not always be applicable.
  • There is a need for simpler, more accessible prognostic models.

Purpose of the Study:

  • To develop parsimonious models for estimating metastasis mortality in choroidal melanoma patients.
  • To provide prognostic tools for situations where LUMPO or TNM staging is not feasible.
  • To assess the predictive accuracy of these new models against existing systems.

Main Methods:

  • A backward-selection algorithm was used to identify key predictors of metastatic death.
  • Largest basal tumor diameter (LBTD) and chromosome 3 status (C3S) were identified as significant prognostic factors.
  • Two prognostic models were developed incorporating LBTD and C3S, utilizing the Aalen estimator for competing risks and bootstrap for accuracy assessment (C-index).

Main Results:

  • The study analyzed 8348 patients with choroidal melanoma, including 4174 with known chromosome 3 status.
  • Of 1553 deaths, 956 were due to metastasis.
  • Models incorporating LBTD (with or without C3S) demonstrated strong predictive accuracy (C-indices at 10 years: 0.84 and 0.74, respectively), outperforming the 8th edition TNM staging system (0.76).

Conclusions:

  • Parsimonious models based on LBTD and C3S have been developed for predicting metastatic death risk in choroidal melanoma.
  • These models effectively account for competing causes of death and show favorable performance compared to the TNM staging system.
  • Further validation studies are recommended for broader clinical application, especially when LUMPO or TNM are not usable.